Werner Schäfer, the founder of CIS Pharma, envisioned the synthesis of a bio-inspired synthetic structure for tissue regeneration. We have generated a platform of proprietary polymers together with a toolkit to create biomaterials specific to their application and site of use. We are continuously expanding platform püolymers to create new applications in the field of nanotechnology, diagnostics and biomedicine.
Projects include
- contact lens coating for increased wear comfort
- membranes to be used as an implant at the interphase of soft &hard tissue
- PEEK surface coating technologies
- scaffolds to create extracellular matrices by 3D-printing and other formation technologies
Both platform monomers as well as polymers show excellent biocompatibility, superior to most commonly used building blocks in the implant industry. The safety of our building blocks has been demonstrated: no cytotoxic, allergic or hemolytic potential was observed. We are also developing biomaterials for our partners for
- tissue regeneration
- the cell culture industry
- lab-on-chip-based assays
- scaffolds releasing active agents